UniQure Shares Rise On Upbeat Q2

Shares of uniQure N.V. (QURE) are currently trading at $28.24, up $1.23 or 4.55%, with trading volume of over 120K versus an average volume of 386K shares. QURE has been trading between $25.80 and $52.19 in the past one year.

Amsterdam, the Netherlands-based gene therapy company reported second-quarter net income of $399.5 million or $8.51 per share compared to a loss of $42.6 million or $0.96 per share last year.

Revenue for the quarter were $463.9 million, higher than the previous year's revenue of $1.5 million, reflecting $462.4 million of license revenue recognized from the CSL Behring Agreement.

Analysts polled by Thomson Reuters expected earnings of $2.96 per share on revenue of $190.02 million for the quarter. Analysts' estimate typically exclude certain special items.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Intelligent Investor.
Follow RTT